Clinical and Laboratory Update in Thrombosis and Anticoagulation

October 1-2, 2009
Kahler Grand Hotel
Rochester, Minnesota

Faculty

Course co-directors

Robert D. McBane, MD
Consultant, Division of Cardiovascular Diseases
Associate Professor of Medicine
Mayo Clinic College of Medicine
Mayo Clinic
Rochester, Minnesota

Rajiv K. Pruthi, MBBS
Consultant, Hematology/Internal Medicine and Laboratory Medicine
Mayo Special Coagulation Laboratories and Coagulation Clinical Centers
Co-Director, Mayo Special Coagulation DNA Diagnostic Laboratory
Co-Director, Coagulation Clinical and Laboratory Practice
Director, Mayo Comprehensive Hemophilia Center
Assistant Professor of Medicine
Mayo Clinic College of Medicine
Rochester, Minnesota

Mayo Clinic Faculty

Letitia A. Acquah, MD
Senior Associate Consultant, Division of General Internal Medicine
Department of Internal Medicine
Instructor in Medicine*

Naser M. Ammash, MD
Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Associate Professor of Medicine*

Aneel A. Ashrani, MD
Senior Associate Consultant, Division of Hematology
Department of Internal Medicine
Assistant Professor of Medicine*

Linnea M. Baudhuin, PhD
Co-Director, Cardiovascular Laboratory Medicine
Co-Director, Nucleotide Polymorphism Laboratory
Consultant, Division of Clinical Biochemistry & Immunology
Assistant Professor, Department of Laboratory Medicine and Pathology

Robert D. Brown Jr., MD, MPH
Chair, Department of Neurology
Professor of Neurology*

Mark G. Costopoulos, MD
Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Instructor in Medicine*

Paul R. Daniels, MD
Consultant, General Internal Medicine
Department of Internal Medicine
Instructor in Medicine*

Audra A. Duncan, MD
Consultant, Division of Vascular Surgery
Department of Surgery
Assistant Professor of Surgery*

Michelle A. Elliott, MD
Consultant, Division of Hematology
Department of Internal Medicine
Assistant Professor of Medicine*

John A. Heit, MD
Director, Coagulation Laboratories and Clinic
Consultant, Division of Cardiovascular Diseases, Hematology, Hematopathology and Laboratory Genetics
Department of Internal Medicine
Professor of Medicine*

Scott C. Litin, MD
Consultant, General Internal Medicine
Department of Internal Medicine
Professor of Medicine*

Ian R. McPhail, MD
Consultant, Cardiovascular Diseases and Interventional Radiology
Department of Internal Medicine
Instructor in Medicine*

Irene Meissner, MD
Consultant, Department of Neurology
Professor of Neurology*

George W. Petty, MD
Consultant, Department of Neurology
Associate Professor of Neurology*

David H. Pfizenmaier, II, MD, DPM
Senior Associate Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Intructor of Medicine*

Charanjit S. Rihal, MD
Director, Cardiac Catheterization Laboratory
Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Professor of Medicine*

Win K. Shen, MD
Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Professor of Medicine*

Raymond C. Shields, MD
Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Instructor in Medicine*

Carole A. Warnes, MD
Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Professor of Medicine*

Timothy J. Welch, MD
Consultant, Department of Radiology
Associate Professor of Radiology*

Alexandra P. Wolanskyj, MD
Consultant, Division of Hematology
Department of Internal Medicine
Education Chair, Division of Hematology
Assistant Professor of Medicine*

Waldemar E. Wysokinski, MD
Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Assistant Professor of Medicine*

*  Mayo Clinic College of Medicine
    Mayo Clinic, Rochester, Minnesota

Faculty Disclosure

As a provider accredited by ACCME, College of Medicine, Mayo Clinic (Mayo School of CME) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.